Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant

Gene-based vaccination strategies, specifically viral vectors encoding vaccine immunogens are effective at priming strong immune responses. Mucosal routes offer practical advantages for vaccination by ease of needle-free administration, and immunogen delivery at readily accessible oral/nasal sites t...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Shailbala, Nehete, Pramod N., Yang, Guojun, He, Hong, Nehete, Bharti, Hanley, Patrick W., Barry, Michael A., Sastry, K. Jagannadha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278383/
https://www.ncbi.nlm.nih.gov/pubmed/25553254
http://dx.doi.org/10.3390/vaccines2040686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278383/
https://www.ncbi.nlm.nih.gov/pubmed/25553254
http://dx.doi.org/10.3390/vaccines2040686

Ejemplares similares